Le Lézard
Classified in: Environment, Science and technology, Business
Subject: ERN

Risen Energy Reports Brilliant 2023 Earnings with $4.87 Billion Revenue, Up 20.22%


NINGBO, China, May 8, 2024 /CNW/ -- Risen Energy Co., Ltd. ("the Company"), a globally leading manufacturer of high-performance solar photovoltaic products, has announced its outstanding financial results for 2023, demonstrating significant growth and technological advancements in the solar industry.

According to its latest annual report, in 2023, Risen Energy clocked up approximately 35.33 billion RMB (US$4.87 billion) in revenue, up 20.22% year-on-year. The Company's net profit after deduction of non-recurring profits or losses rose to 1.58 billion RMB (US$218 million) in 2023, marking a 55.77% year-over-year increase. Risen Energy's net assets attributable to equity holders expanded by 62.47% to reach 15.2 billion RMB (US$2.09 billion) in 2023.

Risen Energy has achieved various significant milestones over the last year. Here are a few highlights:

 


As of December 31, 2023
(in RMB)

As of December 31, 2022

As of December 31, 2021

Total assets

54,245,929,430.61

38,358,001,211.15

29,636,736,310.32

Net assets attributable
to equity holders

15,208,422,344.15

9,360,934,883.33

8,478,633,433.49


2023 (in RMB)

2022

2021

Revenues

35,326,804,378.95

29,384,723,133.68

18,830,724,181.12

Net profit attributable to
equity holders

1,363,281,088.79

934,976,466.28

43,317,260.05

Net profit attributable to
equity holders after
deduction of non-
recurring profit or loss

1,582,641,345.52

1,015,980,459.29

648,132,577.21

 

About Risen Energy

Risen Energy, established in 1986 and publicly listed in 2010, is a global Tier 1, "AAA" credit-rated solar photovoltaic product manufacturer and power generation solutions provider. Renowned for techno-commercial innovation, top-quality products, and strong support, the Company's Solar PV solutions are powerful and cost-effective.

SOURCE Risen Energy Co., Ltd


These press releases may also interest you

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...



News published on and distributed by: